Renasant Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,668
Closed -$255K 159
2025
Q1
$255K Sell
3,668
-1,507
-29% -$105K 0.17% 136
2024
Q4
$445K Sell
5,175
-327
-6% -$28.1K 0.29% 97
2024
Q3
$655K Buy
5,502
+919
+20% +$109K 0.43% 79
2024
Q2
$654K Sell
4,583
-141
-3% -$20.1K 0.45% 75
2024
Q1
$607K Sell
4,724
-215
-4% -$27.6K 0.43% 78
2023
Q4
$511K Buy
4,939
+70
+1% +$7.24K 0.41% 80
2023
Q3
$443K Sell
4,869
-311
-6% -$28.3K 0.37% 94
2023
Q2
$419K Sell
5,180
-1,266
-20% -$102K 0.34% 97
2023
Q1
$513K Buy
6,446
+678
+12% +$53.9K 0.4% 84
2022
Q4
$390K Buy
5,768
+150
+3% +$10.2K 0.29% 106
2022
Q3
$280K Buy
5,618
+490
+10% +$24.4K 0.25% 130
2022
Q2
$286K Buy
5,128
+34
+0.7% +$1.9K 0.23% 133
2022
Q1
$283K Hold
5,094
0.19% 157
2021
Q4
$285K Buy
+5,094
New +$285K 0.19% 157
2021
Q3
Sell
-4,894
Closed -$204K 190
2021
Q2
$204K Buy
+4,894
New +$204K 0.15% 183